Titre:
  • Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes
Auteur:Casasnovas, René Olivier; Follows, George; Zijlstra, Josée J.M.; Vermaat, Joost J.S.P.; Kalakonda, Nagesh; Choquet, Sylvain; Neste, Eric Van Den; Hill, Brian; Thieblemont, Catherine; Cavallo, Federica; La Cruz, Fátima De; Kuruvilla, John; Hamad, Nada; Jaeger, Ulrich; Caimi, Paolo; Gurion, Ronit; Warzocha, Krzysztof; Bakhshi, Sameer; Sancho, Juan Manuel; Schuster, Michael; Egyed, Miklos; Offner, Fritz; Vassilakopoulos, Theodoros; Samal, Priyanka; Ku, Matthew; Ma, Xiwen; Chamoun, Kamal; Shah, Jatin; Canales, Miguel; Maerevoet, Marie; Shacham, Sharon; Kauffman, Michael; Goy, Andre
Informations sur la publication:Clinical Lymphoma, Myeloma and Leukemia
Statut de publication:Publié, 2021
Sujet CREF:Cancérologie
Information et communication
Mots-clés:De novo and transformed DLBCL
DLBCL subtypes
Relapsed/refractory DLBCL
Salvage therapy
Treatment response
XPO1
Note générale:SCOPUS: ar.j
DecretOANoAutActif
Langue:Anglais
Identificateurs:urn:issn:2152-2650
info:doi/10.1016/j.clml.2021.07.017
info:pii/S2152265021002998
info:scp/85114235652